XTA

(1-{[2-(3,5-dichlorophenyl)-6-{[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]oxy}pyridin-4-yl]methyl}piperidin-4-yl)acetic acid

Created:	2021-01-12
Last modified:	2022-01-12

Find Related PDB Entry
1 entries where XTA is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	71
Chiral Atom Count	0
Bond Count	75
Aromatic Bond Count	18

2D diagram of XTA

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(1-{[2-(3,5-dichlorophenyl)-6-{[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]oxy}pyridin-4-yl]methyl}piperidin-4-yl)acetic acid
Systematic Name (OpenEye OEToolkits)	2-[1-[[2-[3,5-bis(chloranyl)phenyl]-6-[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]oxy-pyridin-4-yl]methyl]piperidin-4-yl]ethanoic acid
Formula	C₂₈ H₃₂ Cl₂ N₆ O₃
Molecular Weight	571.498
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c2nc(N1CCN(C)CC1)ncc2Oc4cc(CN3CCC(CC(O)=O)CC3)cc(n4)c5cc(cc(c5)Cl)Cl
SMILES	CACTVS	3.385	CN1CCN(CC1)c2ncc(Oc3cc(CN4CCC(CC4)CC(O)=O)cc(n3)c5cc(Cl)cc(Cl)c5)cn2
SMILES	OpenEye OEToolkits	2.0.7	CN1CCN(CC1)c2ncc(cn2)Oc3cc(cc(n3)c4cc(cc(c4)Cl)Cl)CN5CCC(CC5)CC(=O)O
Canonical SMILES	CACTVS	3.385	CN1CCN(CC1)c2ncc(Oc3cc(CN4CCC(CC4)CC(O)=O)cc(n3)c5cc(Cl)cc(Cl)c5)cn2
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN1CCN(CC1)c2ncc(cn2)Oc3cc(cc(n3)c4cc(cc(c4)Cl)Cl)CN5CCC(CC5)CC(=O)O
InChI	InChI	1.03	InChI=1S/C28H32Cl2N6O3/c1-34-6-8-36(9-7-34)28-31-16-24(17-32-28)39-26-11-20(18-35-4-2-19(3-5-35)12-27(37)38)10-25(33-26)21-13-22(29)15-23(30)14-21/h10-11,13-17,19H,2-9,12,18H2,1H3,(H,37,38)
InChIKey	InChI	1.03	AZEJIKZNBHEXCM-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	146241691

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.